RT

Raju Thumma

Active Director Director DIN 09044597
DIN 09044597 First appointment Jan 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value •••• Premium profile

About Raju Thumma

Data last updated:

Raju Thumma is a Director at Madis Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Madis Pharmaceuticals Private Limited reported revenue of ₹22.3 Lakh (FY 2023).

DIN 09044597
Primary Designation Director
Industry Chemicals
First Appointment 27 Jan 2021
Oldest Company Age 5 yrs
Largest company Madis Pharmaceuticals Private Limited · ₹22.3 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jan 20212021₹22.3 Lakh (FY 2023)Active

Board colleagues of Raju Thumma

NameDINCompanyDesignation
Srinivas Rao Madishetty09044596Madis Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Madis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Raju Thumma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raju Thumma

Raju Thumma currently holds 1 directorship: Madis Pharmaceuticals Private Limited (Director, since 27 Jan 2021, revenue ₹22.3 Lakh (FY 2023)).

Raju Thumma was first appointed on 27 Jan 2021 as Director at Madis Pharmaceuticals Private Limited.

The current boards of Raju Thumma's companies include Srinivas Rao Madishetty (Madis Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available